F. Bray, J. Ferlay, I. Soerjomataram, R. L. Siegel, L. A. Torre et al., Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J Clin, vol.68, issue.6, pp.394-424, 2018.

J. D. Seidman, I. Horkayne-szakaly, M. Haiba, C. R. Boice, R. J. Kurman et al., The histologic type and stage distribution of ovarian carcinomas of surface epithelial origin, Int J Gynecol Pathol, vol.23, issue.1, pp.41-45, 2004.

J. A. Ledermann, Front-line therapy of advanced ovarian cancer: new approaches, Ann Oncol, vol.28, issue.8, pp.46-50, 2017.

M. H. Vetter and J. L. Hays, Use of targeted therapeutics in epithelial ovarian cancer: a review of current literature and future directions, Clin Ther, vol.40, issue.3, pp.361-71, 2018.

E. Pujade-lauraine, New treatments in ovarian cancer, Ann Oncol, vol.28, issue.8, pp.57-60, 2017.

R. E. Reinbolt and J. L. Hays, The role of PARP inhibitors in the treatment of gynecologic malignancies, Front Oncol, vol.3, p.237, 2013.

H. Farmer, N. Mccabe, C. J. Lord, A. Tutt, D. A. Johnson et al., Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy, Nature, vol.434, issue.7035, pp.917-938, 2005.

C. R. Calabrese, R. Almassy, S. Barton, M. A. Batey, A. H. Calvert et al., Anticancer chemosensitization and radiosensitization by the novel poly(ADP-ribose) polymerase-1 inhibitor AG14361, J Natl Cancer Inst, vol.96, issue.1, pp.56-67, 2004.

D. Chandrasekaran and R. Manchanda, Germline and somatic genetic testing in ovarian cancer patients, BJOG, vol.125, p.1460, 2018.

M. De-la-hoya, O. Soukarieh, I. López-perolio, A. Vega, L. C. Walker et al., Combined genetic and splicing analysis of BRCA1 c, pp.594-596
URL : https://hal.archives-ouvertes.fr/hal-02336165

, 641A>G] highlights the relevance of naturally occurring in-frame transcripts for developing disease gene variant classification algorithms, Hum Mol Genet, vol.25, issue.11, pp.2256-68, 2016.

D. Baralle and M. Baralle, Splicing in action: assessing disease causing sequence changes, J Med Genet, vol.42, issue.10, pp.737-785, 2005.

B. Wappenschmidt, A. A. Becker, J. Hauke, U. Weber, S. Engert et al., Analysis of 30 putative BRCA1 splicing mutations in hereditary breast and ovarian cancer families identifies exonic splice site mutations that escape in silico prediction, Disponible sur, vol.7, 2012.

J. T. Robinson, H. Thorvaldsdóttir, W. Winckler, M. Guttman, E. S. Lander et al., Integrative genomics viewer, Nat Biotechnol, vol.29, issue.1, pp.24-30, 2011.

C. Béroud, S. I. Letovsky, C. D. Braastad, S. M. Caputo, O. Beaudoux et al., BRCA Share: a collection of clinical BRCA gene variants, Hum Mutat, vol.37, issue.12, pp.1318-1346, 2016.

M. J. Landrum, J. M. Lee, G. R. Riley, W. Jang, W. S. Rubinstein et al., ClinVar: public archive of relationships among sequence variation and human phenotype, Nucleic Acids Res, vol.42, pp.980-985, 2014.

F. Desmet, D. Hamroun, M. Lalande, G. Collod-béroud, M. Claustres et al., Human splicing finder: an online bioinformatics tool to predict splicing signals, Nucleic Acids Res, vol.37, issue.9, p.67, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-00396239

G. Yeo and C. B. Burge, Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals, J Comput Biol, vol.11, issue.2-3, pp.377-94, 2004.

P. Gaildrat, S. Krieger, J. Théry, A. Killian, A. Rousselin et al., The BRCA1 c.5434C?>G (p.Pro1812Ala) variant induces a deleterious exon 23 skipping by affecting exonic splicing regulatory elements, J Med Genet, vol.47, issue.6, pp.398-403, 2010.
URL : https://hal.archives-ouvertes.fr/hal-02336376

G. M. Findlay, R. M. Daza, B. Martin, M. D. Zhang, A. P. Leith et al., Accurate classification of BRCA1 variants with saturation genome editing, Nature, vol.562, issue.7726, pp.217-239, 2018.

A. Y. Steffensen, M. Dandanell, L. Jønson, B. Ejlertsen, A. Gerdes et al., Functional characterization of BRCA1 gene variants by mini-gene splicing assay, Eur J Hum Genet, vol.22, issue.12, pp.1362-1370, 2014.

A. M. Jansen, H. M. Van-der-klift, M. A. Roos, J. D. Van-eendenburg, C. M. Tops et al., RNA analysis of cancer predisposing genes in formalin-fixed paraffin-embedded tissue determines aberrant splicing, Eur J Hum Genet, vol.26, issue.8, pp.1143-50, 2018.